Thinksulin vs GLAUC
Price, ratings, monetisation and update history for both apps, side by side โ with what reviewers say about each.
Thinksulin
Read full descriptionHide full description
Thinksulin was developed by ACI in consultation with the NSW Diabetes Taskforce and its In-hospital Management of Diabetes Mellitus Working Group and informed by: an evidence check of best practice care components of inpatient insulin management brokered by the Sax Institute for the Agency for Clinical Innovation (2024); clinician and consumer consultations; and clinical expertise. Thinksulin aims to enhance the capacity and/or capability of junior medical officers and nursing staff responsible for prescribing and administering of insulin to patients in hospital with diabetes, although it can be used by any clinician responsible for the care of people in hospital with diabetes. Thinksulin is a point of care app that provides information and decision support on blood glucose level targets, hypoglycaemia management, blood glucose monitoring, basal-bolus calculations, and charting and reviewing doses.
GLAUC
Read full descriptionHide full description
GLAUC-STRAT Calc brings the RCOphth and UKEGS GLAUC-STRAT-FAST glaucoma risk stratification tool to your phone, for clinicians and their patients. For clinicians - Enter MD loss for each eye and the glaucoma type, then add red flags, ophthalmic and systemic factors - See the nine-level Red, Amber, Green result on the 3x3 grid in seconds - Check in patients by scanning their QR code, or find your own patients by name - Save each assessment to the patient's history For patients - Show your QR code at your visit - Follow the mean deviation loss for each eye over time, colour coded by result band Privacy - Sharing anonymised results for glaucoma research is opt-in - An approximate location is added only with your consent - Delete your account at any time from Settings GLAUC-STRAT Calc supports clinical decision making. It does not diagnose glaucoma or replace clinical judgement.
Screenshots
Verdict
The clearest difference is update cadence: GLAUC at weekly against Thinksulin's every 9 months. GLAUC also leads on iOS requirement (15.0 vs 17.2). On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price ยท Rating ยท Positive reviews ยท Number of ratings ยท Update frequency ยท Ads ยท In-app purchases ยท Monetization ยท Best chart rank ยท Devices ยท Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Thinksulin ships an update every 9 months, GLAUC weekly. The most recent releases landed on October 10, 2026 and October 17, 2026 respectively.
| Parameter | Thinksulin | GLAUC |
|---|---|---|
| Price | Free | Free |
| Update frequency | Every 9 months | Weekly โ better |
| Ads | No | No |
| In-app purchases | No | No |
| Devices | iPhone, iPad | iPhone, iPad, iPod โ better |
| Requires iOS | 17.2 | 15.0 โ better |
| Further details โ not scored | ||
| Size | 7 MB | 20 MB |
| Age rating | 17+ | 17+ |
| Developer | Agency for Clinical Innovation | Chun-Huei Liu |
In-app purchases
Thinksulin
No in-app purchases
GLAUC
No in-app purchases







